{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:06:47Z","timestamp":1790996807957,"version":"4.1.0"},"reference-count":97,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T00:00:00Z","timestamp":1595203200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007028","name":"Leona M. and Harry B. Helmsley Charitable Trust","doi-asserted-by":"publisher","award":["2007-04026"],"award-info":[{"award-number":["2007-04026"]}],"id":[{"id":"10.13039\/100007028","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>The microbiome is an important contributor to a variety of fundamental aspects of human health, including host metabolism, infection, and the immune response. Gut dysbiosis has been identified as a contributor to the errant immune response in a variety of immune-mediated inflammatory diseases (IMIDs), such as inflammatory bowel disease (IBD), rheumatoid arthritis (RA), and psoriatic disease (psoriasis and psoriatic arthritis). Given this, probiotics and prebiotics have been investigated as therapeutic options in these disease states. In our review, we highlight the current evidence on prebiotics and probiotics as well as other supplements (such as fish oils, vitamin D, and curcumin) as therapies for IBD. Recommendations, however, regarding the specific use of such supplements in IBD have been lacking, particularly from professional societies, often due to study limitations related to small sample sizes and design heterogeneity. Hence, we additionally examine the literature on the use of prebiotics, probiotics, and other supplements in related IMIDs, namely RA and psoriasis\/psoriatic arthritis, as these diseases share many approved therapeutic options with IBD. Based on these combined findings, we offer additional evidence that may help guide clinicians in their treatment of patients with IBD (and other IMIDs) and provide recommendations on potential next steps in therapeutic research in this area.<\/jats:p>","DOI":"10.3390\/nu12072156","type":"journal-article","created":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T10:59:38Z","timestamp":1595242778000},"page":"2156","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Efficacy of Dietary Supplements in Inflammatory Bowel Disease and Related Autoimmune Diseases"],"prefix":"10.3390","volume":"12","author":[{"given":"Priyanka","family":"Jadhav","sequence":"first","affiliation":[{"name":"Northwestern University, Evanston, IL 60208, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Jiang","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology &amp; Hepatology, Department of Medicine, Stanford University, Redwood City, CA 94063, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolin","family":"Jarr","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology &amp; Hepatology, Department of Medicine, Stanford University, Redwood City, CA 94063, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cosima","family":"Layton","sequence":"additional","affiliation":[{"name":"University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8405-7503","authenticated-orcid":false,"given":"Judith F.","family":"Ashouri","sequence":"additional","affiliation":[{"name":"Rosalind Russell and Ephraim P. Engleman Rheumatology Research Center, Division of Rheumatology, Department of Medicine, University of California, San Francisco, CA 94143, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5104-6410","authenticated-orcid":false,"given":"Sidhartha R.","family":"Sinha","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology &amp; Hepatology, Department of Medicine, Stanford University, Redwood City, CA 94063, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,7,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1136\/gutjnl-2018-316723","article-title":"Human gut microbiome: Hopes, threats and promises","volume":"67","author":"Cani","year":"2018","journal-title":"Gut"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Young, V.B. (2017). The role of the microbiome in human health and disease: An introduction for clinicians. BMJ, 356.","DOI":"10.1136\/bmj.j831"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/imm.12231","article-title":"The microbiome and regulation of mucosal immunity","volume":"142","author":"McDermott","year":"2014","journal-title":"Immunology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.rdc.2014.07.013","article-title":"Mucosal immune responses to microbiota in the development of autoimmune disease","volume":"40","author":"Kuhn","year":"2014","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nature18848","article-title":"The microbiota in adaptive immune homeostasis and disease","volume":"535","author":"Honda","year":"2016","journal-title":"Nature"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/cmi.12308","article-title":"Defining dysbiosis and its influence on host immunity and disease","volume":"16","author":"Petersen","year":"2014","journal-title":"Cell. Microbiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.chom.2020.01.021","article-title":"Dysbiosis-Induced Secondary Bile Acid Deficiency Promotes Intestinal Inflammation","volume":"27","author":"Sinha","year":"2020","journal-title":"Cell Host Microbe"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/imr.12567","article-title":"Gut microbiota: Role in pathogen colonization, immune responses, and inflammatory disease","volume":"279","author":"Pickard","year":"2017","journal-title":"Immunol. Rev."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Markowiak, P., and \u015ali\u017cewska, K. (2017). Effects of Probiotics, Prebiotics, and Synbiotics on Human Health. Nutrients, 9.","DOI":"10.3390\/nu9091021"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.cgh.2018.09.028","article-title":"Prebiotics and Probiotics in Digestive Health","volume":"17","author":"Quigley","year":"2019","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.gtc.2017.08.011","article-title":"Vitamins and Minerals in Inflammatory Bowel Disease","volume":"46","author":"Ghishan","year":"2017","journal-title":"Gastroenterol. Clin. N. Am."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/MPG.0b013e31826a105d","article-title":"Vitamin and mineral status in patients with inflammatory bowel disease","volume":"56","author":"Alkhouri","year":"2013","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrgastro.2015.34","article-title":"Epidemiology and risk factors for IBD","volume":"12","author":"Ananthakrishnan","year":"2015","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.semarthrit.2019.05.007","article-title":"A cross talk between dysbiosis and gut-associated immune system governs the development of inflammatory arthropathies","volume":"49","author":"Kalinkovich","year":"2019","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.rdc.2015.07.006","article-title":"Etiology and Pathogenesis of Psoriatic Arthritis","volume":"41","author":"Barnas","year":"2015","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/nm.3914","article-title":"The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment","volume":"21","author":"Zhang","year":"2015","journal-title":"Nat. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/s41575-020-0273-0","article-title":"JAK-STAT pathway targeting for the treatment of inflammatory bowel disease","volume":"17","author":"Salas","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"i43","DOI":"10.1093\/rheumatology\/key276","article-title":"JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis","volume":"58","author":"Fragoulis","year":"2019","journal-title":"Rheumatol. Oxf. Engl."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1053\/j.gastro.2020.01.001","article-title":"Safety of Janus Kinase Inhibitors in Patients with Inflammatory Bowel Diseases or Other Immune-mediated Diseases: A Systematic Review and Meta-Analysis","volume":"158","author":"Olivera","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1159\/000481401","article-title":"Gut Microbiome in Inflammatory Bowel Disease and Other Chronic Immune-Mediated Inflammatory Diseases","volume":"2","author":"Bernstein","year":"2017","journal-title":"Inflamm. Intest. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Su, G.L., Ko, C.W., Bercik, P., Falck-Ytter, Y., Sultan, S., Weizman, A.V., and Morgan, R.L. (2020). AGA Clinical Practice Guidelines on the Role of Probiotics in the Management of Gastrointestinal Disorders. Gastroenterology.","DOI":"10.1053\/j.gastro.2020.05.059"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3390\/nu3020245","article-title":"Probiotics in Inflammatory Bowel Diseases and Associated Conditions","volume":"3","author":"Mack","year":"2011","journal-title":"Nutrients"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/ncpgasthep0528","article-title":"Mechanisms of disease: Pathogenesis of Crohn\u2019s disease and ulcerative colitis","volume":"3","author":"Sartor","year":"2006","journal-title":"Nat. Clin. Pract. Gastroenterol. Hepatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/ibd.20174","article-title":"Bacteria- and host-derived mechanisms to control intestinal epithelial cell homeostasis: Implications for chronic inflammation","volume":"13","author":"Clavel","year":"2007","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1002\/jcp.25911","article-title":"Probiotics are a good choice in remission of inflammatory bowel diseases: A meta analysis and systematic review","volume":"233","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Peng, L., Zhong, Y., Wang, A., and Jiang, Z. (2019). Probiotics combined with aminosalicylic acid affiliates remission of ulcerative colitis: A meta-analysis of randomized controlled trial. Biosci. Rep., 39.","DOI":"10.1042\/BSR20180943"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.cgh.2009.07.016","article-title":"The probiotic preparation, VSL#3 induces remission in patients with mild-to-moderately active ulcerative colitis","volume":"7","author":"Sood","year":"2009","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1136\/gut.2003.037747","article-title":"Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine","volume":"53","author":"Kruis","year":"2004","journal-title":"Gut"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.3748\/wjg.v16.i15.1908","article-title":"Remission induction and maintenance effect of probiotics on ulcerative colitis: A meta-analysis","volume":"16","author":"Sang","year":"2010","journal-title":"World J. Gastroenterol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.cgh.2014.10.031","article-title":"The probiotic VSL#3 has anti-inflammatory effects and could reduce endoscopic recurrence after surgery for Crohn\u2019s disease","volume":"13","author":"Fedorak","year":"2015","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Kaur, L., Gordon, M., Baines, P.A., Iheozor-Ejiofor, Z., Sinopoulou, V., and Akobeng, A.K. (2020). Probiotics for induction of remission in ulcerative colitis. Cochrane Database Syst. Rev., 3.","DOI":"10.1002\/14651858.CD005573.pub3"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Mallon, P., McKay, D., Kirk, S., and Gardiner, K. (2007). Probiotics for induction of remission in ulcerative colitis. Cochrane Database Syst. Rev., CD005573.","DOI":"10.1002\/14651858.CD005573.pub2"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1038\/ajg.2010.218","article-title":"Treatment of Relapsing Mild-to-Moderate Ulcerative Colitis With the Probiotic VSL#3 as Adjunctive to a Standard Pharmaceutical Treatment: A Double-Blind, Randomized, Placebo-Controlled Study","volume":"105","author":"Tursi","year":"2010","journal-title":"Am. J. Gastroenterol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.crohns.2014.06.001","article-title":"Ciprofloxacin and probiotic Escherichia coli Nissle add-on treatment in active ulcerative colitis: A double-blind randomized placebo controlled clinical trial","volume":"8","author":"Petersen","year":"2014","journal-title":"J. Crohns Colitis"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Schultz, M., Timmer, A., Herfarth, H.H., Sartor, R.B., Vanderhoof, J.A., and Rath, H.C. (2004). Lactobacillus GG in inducing and maintaining remission of Crohn\u2019s disease. BMC Gastroenterol., 4.","DOI":"10.1186\/1471-230X-4-5"},{"key":"ref_36","unstructured":"(2020, June 02). Lactobacillus Rhamnosus GG (ATCC 53103) in Mild-Moderately Active UC Patients ClinicalTrials.gov, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04102852."},{"key":"ref_37","unstructured":"(2020, June 02). A Study to Assess Efficacy and Safety of SER-287 in Adults with Active Mild-to-Moderate Ulcerative Colitis (ECO-RESET) ClinicalTrials.gov, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03759041."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1007\/s10620-018-4946-2","article-title":"Efficacy of Bifidobacterium breve Fermented Milk in Maintaining Remission of Ulcerative Colitis","volume":"63","author":"Matsuoka","year":"2018","journal-title":"Dig. Dis. Sci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/00004836-199712000-00021","article-title":"Crohn\u2019s disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn\u2019s disease?","volume":"25","author":"Malchow","year":"1997","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1136\/gut.2005.076604","article-title":"Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn\u2019s disease: A randomised, double blind, placebo controlled GETAID trial","volume":"55","author":"Marteau","year":"2006","journal-title":"Gut"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/ibd.20063","article-title":"Multicenter randomized-controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn\u2019s disease after lleo-caecal resection","volume":"13","author":"Dewit","year":"2007","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.cgh.2013.02.021","article-title":"Saccharomyces boulardii does not prevent relapse of Crohn\u2019s disease","volume":"11","author":"Bourreille","year":"2013","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/1756-185X.12333","article-title":"Effects of Lactobacillus casei supplementation on disease activity and inflammatory cytokines in rheumatoid arthritis patients: A randomized double-blind clinical trial","volume":"17","author":"Alipour","year":"2014","journal-title":"Int. J. Rheum. Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/1756-185X.12888","article-title":"Clinical and metabolic response to probiotic supplementation in patients with rheumatoid arthritis: A randomized, double-blind, placebo-controlled trial","volume":"19","author":"Zamani","year":"2016","journal-title":"Int. J. Rheum. Dis."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Mandel, D.R., Eichas, K., and Holmes, J. (2010). Bacillus coagulans: A viable adjunct therapy for relieving symptoms of rheumatoid arthritis according to a randomized, controlled trial. BMC Complement. Altern. Med., 10.","DOI":"10.1186\/1472-6882-10-1"},{"key":"ref_46","first-page":"1078","article-title":"Efficacy and Safety of Oral Administration of a Mixture of Probiotic Strains in Patients with Psoriasis: A Randomized Controlled Clinical Trial","volume":"99","year":"2019","journal-title":"Acta Derm. Venereol."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"H\u00e4ger, J., Bang, H., Hagen, M., Frech, M., Tr\u00e4ger, P., Sokolova, M.V., Steffen, U., Tascilar, K., Sarter, K., and Schett, G. (2019). The Role of Dietary Fiber in Rheumatoid Arthritis Patients: A Feasibility Study. Nutrients, 11.","DOI":"10.3390\/nu11102392"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1080\/19490976.2018.1526583","article-title":"Inulin-type fructans improve active ulcerative colitis associated with microbiota changes and increased short-chain fatty acids levels","volume":"10","author":"Valcheva","year":"2019","journal-title":"Gut Microbes"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1136\/annrheumdis-2013-204145","article-title":"Fish oil in recent onset rheumatoid arthritis: A randomised, double-blind controlled trial within algorithm-based drug use","volume":"74","author":"Proudman","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/03009742.2017.1287304","article-title":"Beneficial effect of n-3 polyunsaturated fatty acids on inflammation and analgesic use in psoriatic arthritis: A randomized, double blind, placebo-controlled trial","volume":"47","author":"Kristensen","year":"2018","journal-title":"Scand. J. Rheumatol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1007\/s00296-011-1944-5","article-title":"Efficacy of Vitamin D in patients with active rheumatoid arthritis receiving methotrexate therapy","volume":"32","author":"Salesi","year":"2012","journal-title":"Rheumatol. Int."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1089\/jmf.2017.3930","article-title":"A Novel Highly Bioavailable Curcumin Formulation Improves Symptoms and Diagnostic Indicators in Rheumatoid Arthritis Patients: A Randomized, Double-Blind, Placebo-Controlled, Two-Dose, Three-Arm, and Parallel-Group Study","volume":"20","author":"Amalraj","year":"2017","journal-title":"J. Med. Food"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.nut.2013.09.007","article-title":"Probiotic supplementation improves inflammatory status in patients with rheumatoid arthritis","volume":"30","author":"Alipour","year":"2014","journal-title":"Nutrition"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jfda.2016.06.003","article-title":"Lactobacillus pentosus GMNL-77 inhibits skin lesions in imiquimod-induced psoriasis-like mice","volume":"25","author":"Chen","year":"2017","journal-title":"J. Food Drug Anal."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"325","DOI":"10.4161\/gmic.25487","article-title":"Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut","volume":"4","author":"Groeger","year":"2013","journal-title":"Gut Microbes"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Davani-Davari, D., Negahdaripour, M., Karimzadeh, I., Seifan, M., Mohkam, M., Masoumi, S.J., Berenjian, A., and Ghasemi, Y. (2019). Prebiotics: Definition, Types, Sources, Mechanisms, and Clinical Applications. Foods, 8.","DOI":"10.3390\/foods8030092"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.2174\/1381612824666181001153605","article-title":"Protective Mechanisms of Butyrate on Inflammatory Bowel Disease","volume":"24","author":"Silva","year":"2018","journal-title":"Curr. Pharm. Des."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Mohammed Vashist, N., Samaan, M., Mosli, M.H., Parker, C.E., MacDonald, J.K., Nelson, S.A., Zou, G.Y., Feagan, B.G., Khanna, R., and Jairath, V. (2018). Endoscopic scoring indices for evaluation of disease activity in ulcerative colitis. Cochrane Database Syst. Rev., 1.","DOI":"10.1002\/14651858.CD011450.pub2"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/j.1365-2036.2007.03288.x","article-title":"Oral oligofructose-enriched inulin supplementation in acute ulcerative colitis is well tolerated and associated with lowered faecal calprotectin","volume":"25","author":"Casellas","year":"2007","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_60","first-page":"116","article-title":"Effects of an Oral Supplementation of Germinated Barley Foodstuff on Serum CRP Level and Clinical Signs in Patients with Ulcerative Colitis","volume":"4","author":"Faghfoori","year":"2014","journal-title":"Health Promot. Perspect."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1136\/gut.2005.074971","article-title":"Clinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn\u2019s disease","volume":"55","author":"Lindsay","year":"2006","journal-title":"Gut"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1136\/gut.2010.232025","article-title":"Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn\u2019s disease","volume":"60","author":"Benjamin","year":"2011","journal-title":"Gut"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1053\/j.gastro.2013.07.050","article-title":"A prospective study of long-term intake of dietary fiber and risk of Crohn\u2019s disease and ulcerative colitis","volume":"145","author":"Ananthakrishnan","year":"2013","journal-title":"Gastroenterology"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Forbes, J.D., Van Domselaar, G., and Bernstein, C.N. (2016). The Gut Microbiota in Immune-Mediated Inflammatory Diseases. Front. Microbiol., 7.","DOI":"10.3389\/fmicb.2016.01081"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Franco, A.S., Freitas, T.Q., Bernardo, W.M., and Pereira, R.M.R. (2017). Vitamin D supplementation and disease activity in patients with immune-mediated rheumatic diseases. Medicine (Baltimore), 96.","DOI":"10.1097\/MD.0000000000007024"},{"key":"ref_66","first-page":"8537","article-title":"Nutritional strategies for psoriasis: Current scientific evidence in clinical trials","volume":"22","author":"Zuccotti","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1097\/MEG.0000000000000728","article-title":"The role of dietary supplements in inflammatory bowel disease: A systematic review","volume":"28","author":"Rossi","year":"2016","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.bbalip.2014.08.010","article-title":"Marine omega-3 fatty acids and inflammatory processes: Effects, mechanisms and clinical relevance","volume":"1851","author":"Calder","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Lev-Tzion, R., Griffiths, A.M., Leder, O., and Turner, D. (2014). Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn\u2019s disease. Cochrane Database Syst. Rev., CD006320.","DOI":"10.1002\/14651858.CD006320.pub4"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S1542-3565(04)00672-X","article-title":"An oral supplement enriched with fish oil, soluble fiber, and antioxidants for corticosteroid sparing in ulcerative colitis: A randomized, controlled trial","volume":"3","author":"Seidner","year":"2005","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1017\/S0029665110001564","article-title":"Fish oil and rheumatoid arthritis: Past, present and future","volume":"69","author":"James","year":"2010","journal-title":"Proc. Nutr. Soc."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.jaad.2014.03.016","article-title":"Diet and psoriasis, part III: Role of nutritional supplements","volume":"71","author":"Millsop","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Yang, S.-J., and Chi, C.-C. (2019). Effects of fish oil supplement on psoriasis: A meta-analysis of randomized controlled trials. BMC Complement. Altern. Med., 19.","DOI":"10.1186\/s12906-019-2777-0"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1136\/gut.2010.228866","article-title":"IBD and arthropathies: A practical approach to its diagnosis and management","volume":"60","author":"Brakenhoff","year":"2011","journal-title":"Gut"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1097\/MIB.0000000000000392","article-title":"Extraintestinal Manifestations of Inflammatory Bowel Disease","volume":"21","author":"Vavricka","year":"2015","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00011-014-0755-z","article-title":"Inflammation and vitamin D: The infection connection","volume":"63","author":"Mangin","year":"2014","journal-title":"Inflamm. Res."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-Mu\u00f1oz, P., Beltr\u00e1n, B., S\u00e1ez-Gonz\u00e1lez, E., Alba, A., Nos, P., and Iborra, M. (2019). Influence of Vitamin D Deficiency on Inflammatory Markers and Clinical Disease Activity in IBD Patients. Nutrients, 11.","DOI":"10.3390\/nu11051059"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/ijd.12790","article-title":"The role of vitamin D in psoriasis: A review","volume":"54","author":"Soleymani","year":"2015","journal-title":"Int. J. Dermatol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3109\/09546639009086743","article-title":"Vitamin D3 and psoriasis: A randomized double-blind placebo-controlled study","volume":"1","author":"Siddiqui","year":"1990","journal-title":"J. Dermatol. Treat."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Fletcher, J., Cooper, S.C., Ghosh, S., and Hewison, M. (2019). The Role of Vitamin D in Inflammatory Bowel Disease: Mechanism to Management. Nutrients, 11.","DOI":"10.3390\/nu11051019"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1080\/10408398.2015.1077195","article-title":"Curcumin, an active component of turmeric (Curcuma longa), and its effects on health","volume":"57","author":"Kocaadam","year":"2017","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"ref_82","first-page":"9183","article-title":"Curcumin, inflammation, and chronic diseases: How are they linked?","volume":"20","author":"He","year":"2015","journal-title":"Mol. Basel Switz."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.cgh.2015.02.019","article-title":"Curcumin in Combination With Mesalamine Induces Remission in Patients With Mild-to-Moderate Ulcerative Colitis in a Randomized Controlled Trial","volume":"13","author":"Lang","year":"2015","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4292\/wjgpt.v8.i2.147","article-title":"Low dose oral curcumin is not effective in induction of remission in mild to moderate ulcerative colitis: Results from a randomized double blind placebo controlled trial","volume":"8","author":"Kedia","year":"2017","journal-title":"World J. Gastrointest. Pharmacol. Ther."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1111\/1756-185X.13688","article-title":"Effect of curcumin nanomicelle on the clinical symptoms of patients with rheumatoid arthritis: A randomized, double-blind, controlled trial","volume":"22","author":"Javadi","year":"2019","journal-title":"Int. J. Rheum. Dis."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1002\/ptr.4639","article-title":"A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis","volume":"26","author":"Chandran","year":"2012","journal-title":"Phytother. Res."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Campbell, N.K., Fitzgerald, H.K., Malara, A., Hambly, R., Sweeney, C.M., Kirby, B., Fletcher, J.M., and Dunne, A. (2018). Naturally derived Heme-Oxygenase 1 inducers attenuate inflammatory responses in human dendritic cells and T cells: Relevance for psoriasis treatment. Sci. Rep., 8.","DOI":"10.1038\/s41598-018-28488-6"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Sun, J., Zhao, Y., and Hu, J. (2013). Curcumin Inhibits Imiquimod-Induced Psoriasis-Like Inflammation by Inhibiting IL-1beta and IL-6 Production in Mice. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0067078"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1136\/pgmj.2005.040899","article-title":"Probiotics and inflammatory bowel diseases","volume":"82","author":"Bai","year":"2006","journal-title":"Postgrad. Med. J."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000073243","article-title":"Rationale for probiotic and antibiotic treatment strategies in inflammatory bowel diseases","volume":"21","author":"Schultz","year":"2003","journal-title":"Dig. Dis. Basel Switz."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1136\/gut.35.4.483","article-title":"Lactobacillus acidophilus LA 1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria","volume":"35","author":"Bernet","year":"1994","journal-title":"Gut"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1023\/A:1024115411253","article-title":"Luminal fermentation and colonocyte metabolism in a rat model of enteral nutrition","volume":"48","author":"Babakissa","year":"2003","journal-title":"Dig. Dis. Sci."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1093\/jn\/129.12.2231","article-title":"Prolonged intake of fructo-oligosaccharides induces a short-term elevation of lactic acid-producing bacteria and a persistent increase in cecal butyrate in rats","volume":"129","author":"Michel","year":"1999","journal-title":"J. Nutr."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1053\/gast.1997.v113.pm9247468","article-title":"Short-chain fatty acids promote the migration of colonic epithelial cells in vitro","volume":"113","author":"Wilson","year":"1997","journal-title":"Gastroenterology"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1080\/003655201300192012","article-title":"Effect of sodium butyrate on reactive oxygen species generation by human neutrophils","volume":"36","author":"Liu","year":"2001","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrgastro.2015.186","article-title":"Immunopathogenesis of IBD: Current state of the art","volume":"13","author":"Fiocchi","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1056\/NEJM198902023200501","article-title":"The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells","volume":"320","author":"Endres","year":"1989","journal-title":"N. Engl. J. Med."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/12\/7\/2156\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:50:02Z","timestamp":1760176202000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/12\/7\/2156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,20]]},"references-count":97,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,7]]}},"alternative-id":["nu12072156"],"URL":"https:\/\/doi.org\/10.3390\/nu12072156","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,20]]}}}